louisiana semaglutide ban Study shows rise in weight loss injections, but patients face hurdles Bill could expand Medicaid access

JAMA 2015;314(7):687699

Significant Weight Loss Benchmarks The study found that over a one-year period, patients on Mounjaro were three times as likely to achieve a weight loss of 15% or more compared to those on Ozempic

It is typically diagnosed after ruling out life-threatening causes through history, physical exam, ECG, and sometimes imaging or lab tests

Your doctor would need to prescribe it specifically for cardiovascular risk reduction, not weight management

Approved Uses, Evidence, and Clinical Trial Data Tesamorelin has established Phase 3 evidence and US FDA approval for HIV-related lipodystrophy

Building muscle while losing fat can result in modest weight changes despite substantial improvements in how you look and feel